Dehydration represents an important factor, as GLP-1 medications can cause nausea, vomiting, and diarrhea, particularly during dose escalation, leading to volume depletion
The chewable tablet has a pleasant lemon mint flavor
Respondents expressed that their top concern (33%) if access to peptide therapies expands is that patients will self-direct treatment without medical oversight, followed by being able to monitor the safety and side effects
Two caveats temper the result: nausea occurred in 46% of lixisenatide-treated participants and vomiting in 13%, raising the possibility of functional unblinding, and the MDS-UPDRS is a clinical scale rather than a direct measure of dopaminergic neuron survival
She received only intravenous ceftriaxone 1 g 1 h before induction
Telehealth provider availability may vary by state